OpenFilings

Jasper Therapeutics, Inc.

Form10-Q

Report Period2026-09-30

Date Filed2026-11-16

Time Filed08:05:36

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

QUARTERLY REPORT
LICENSE AGREEMENT, DATED JUNE 9, 2017, BY AND BETWEEN THE TRUSTEES OF THE UNIVER
FIRST AMENDMENT TO LICENSE AGREEMENT, DATED JUNE 7, 2019, BY AND BETWEEN THE TRU
SECOND AMENDMENT TO LICENSE AGREEMENT, DATED FEBRUARY 4, 2021, BY AND BETWEEN TH
THIRD AMENDMENT TO LICENSE AGREEMENT, DATED JULY 9, 2026, BY AND BETWEEN THE TRU
LICENSE AGREEMENT, DATED JULY 13, 2026, BY AND BETWEEN MIRADOR THERAPEUTICS, INC
LETTER AGREEMENT, DATED JULY 13, 2026, BY AND BETWEEN MIRADOR THERAPEUTICS, INC.
2017 EQUITY INCENTIVE PLAN FOR EMPLOYEES AND CONSULTANTS OF KIRA PHARMACEUTICALS
EMPLOYMENT AGREEMENT, DATED AUGUST 13, 2026, BY AND BETWEEN JASPER THERAPEUTICS,
EMPLOYMENT AGREEMENT, DATED AUGUST 13, 2026, BY AND BETWEEN JASPER THERAPEUTICS,
EMPLOYMENT AGREEMENT, DATED AUGUST 13, 2026, BY AND BETWEEN JASPER THERAPEUTICS,
CERTIFICATION
CERTIFICATION
Filing on SEC Edgar